Oberweis Asset Management’s AtriCure ATRC Stock Holding History
Bought
Maintained
Sold
Other funds holding ATRC
HRCM
VPM
VCM
NAMI
Oberweis Asset Management's ATRC Position: Q1 2026 in Review
Oberweis Asset Management sold out of AtriCure (ATRC) in Q1 2026, closing a stake of 217,992 shares — an estimated $8.62M sold.
Oberweis Asset Management first reported a position in ATRC in Q2 2014 and held it in 19 quarters. The position peaked at $8.62M in Q4 2025. 223 funds tracked by Wall St. Rank hold ATRC as of Q1 2026.
- Oberweis Asset Management reported no remaining AtriCure position as of Q1 2026 after selling out during the quarter.
- Oberweis Asset Management sold 217,992 AtriCure shares in Q1 2026, an estimated $8.62M.
- Oberweis Asset Management first reported a position in AtriCure in Q2 2014 and held it in 19 quarters.
- Oberweis Asset Management's AtriCure position peaked at $8.62M in Q4 2025.
- 223 funds tracked by Wall St. Rank held AtriCure as of Q1 2026.
Based on Oberweis Asset Management's 13F filing for Q1 2026, filed 15 May 2026.